Phendimetrazine Tartrate Tablet
Product Images NDC 17224-800

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Phendimetrazine Tartrate (NDC 17224-800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Calvin Scott & Co., Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

17224-800-28_2 (17224 800 28 2)

17224-800-28_2 (17224 800 28 2)
A prescription drug label for Phendimetrazine 35 mg tablets, indicating a quantity of 28 yellow tablets. The label includes directions to take one tablet daily as directed, and states it is a Schedule III controlled substance with no refill allowed. The labeler is Calvin Scott & Co., Inc. located in Albuquerque, NM. Additional information includes lot number, expiration date, serial number, and a caution about drug transfer restrictions.*
FDA Label Image

17224-800-42_2 (17224 800 42 2)

17224-800-42_2 (17224 800 42 2)
Phendimetrazine 35 mg oral tablets label, showing 42 yellow tablets per bottle. The label includes dosing direction to take one tablet daily as directed. It displays controlled substance classification CIII with RX only and no refill warnings. Labeler is Calvin Scott & Co., Inc., Albuquerque, NM. Includes NDCs 17224-800-42 (CS) and 10702-077-10 (MFG), lot number, expiration date, and cautions regarding federal law transfer restrictions.*
FDA Label Image

17224-800-56_2 (17224 800 56 2)

17224-800-56_2 (17224 800 56 2)
Phendimetrazine 35 mg yellow tablets label showing 56 count. The label includes directions to take one tablet daily as directed. It identifies the product as a Schedule III controlled substance (CIII) with no refill and RX only status. Distributed by Calvin Scott & Co., Inc., Albuquerque, NM.*
FDA Label Image

17224-800-84_2 (17224 800 84 2)

17224-800-84_2 (17224 800 84 2)
Label for Phendimetrazine 35 mg tablets, containing 84 yellow tablets for oral use. The label includes space for provider information, directions to take one tablet daily, and a caution against transferring the drug. Distributed by Calvin Scott & Co, Inc., Albuquerque, NM. It also displays prescription status as CIII, RX only, No refill, along with lot, expiration date, serial number, and QR codes.*
FDA Label Image

Chemical Structure (Figure 01 Chemical Structure)

Chemical Structure (Figure 01 Chemical Structure)
Chemical structure diagram depicting the molecular formula C12H17NO plus C4H6O6 and molecular weight of 341.36. The diagram shows two connected molecules, illustrating the chemical structure of Phendimetrazine Tartrate.*
FDA Label Image
FDA Label Image

Bmi Index (Figure 12 Bmi Index)

Bmi Index (Figure 12 Bmi Index)
A table displaying Body Mass Index (BMI) values calculated based on weight in pounds (140 to 250) and height in feet and inches (5'0" to 6'3"). The table shows BMI values in kg/m², with some cells outlined for emphasis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.